Clinical Trial

A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression

Completed Phase 2
View on ClinicalTrials.gov →
Summary
This is a study evaluating the efficacy, and safety of KH607 in 72 participants diagnosed with Postpartum Depressive Disorder.
Protocol Amendment History 3 changes
critical Completed without a posted recruiting period 2026-07-29
notable Primary completion moved earlier: 2027-01 -> 2026-04-24 2026-07-29
minor Completion moved earlier: 2027-04 -> 2026-04-24 2026-07-29
Trial Details
NCT Number NCT07096791
Lead Sponsor Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Conditions Postpartum Depressive Disorder
Enrollment 72 participants
Start Date 2025-09-02
Primary Completion 2026-04-24 (estimated)
Study Completion 2026-04-24 (estimated)
Updated on ClinicalTrials.gov 2026-07-28